Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the ...
GlobalData on MSN
Health Canada authorises Dexcom G7 15 Day CGM
The device demonstrates a MARD of 8% and includes a 12-hour grace period and mobile app compatibility.
Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be ...
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
1don MSN
Influencers are hopping on a surprising wearable trend that requires a needle — do you need one?
Influencers have found their latest wellness obsession — and, once again, diabetics got there first. First, came GLP-1 drugs.
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
Ahead of the premiere of Camp Rock 3, we caught up with Nick Jonas about returning to Camp Rock as a producer, working with ...
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Financial Highlights: Revenue ...
Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support.
The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
Compare the best Samsung Watch CGM apps and Wear OS tools for blood sugar readings, including Dexcom G6, Gluroo, and xDrip+.
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results